Skip to main content
Egyptian Liver Journal
Fig. 3 | Egyptian Liver Journal

Fig. 3

From: Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c)

Fig. 3

(A) Plasma Catalase (CAT) Activities (B) Liver Catalase (CAT) Activities (C) Plasma Total Protein (TP) concentration (D) Liver Total Protein Concentration of mice after the 1st, 2nd, 3rd, and 6th treatments with either artemether/lumefantrine (A/L) or artesunate/amodiaquine (A/A) compared to the control group. Values are expressed as mean ± SEM (n = 3), and a, b, and c indicate significant differences at p < 0.05, p < 0.01, and p < 0.001, respectively, compared to the corresponding control groups

Back to article page